BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -55.6% | 1,500 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -18.2% | 1,500 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | -61.5% | 1,500 | -50.0% | 0.00% | – |
| Q4 2017 | $26,000 | +52.9% | 3,000 | +100.0% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | -5.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $18,000 | +100.0% | 1,500 | +50.0% | 0.00% | – |
| Q1 2016 | $9,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,026,402 | $21,832,000 | 2.20% |
| Avoro Capital Advisors LLC | 262,515 | $5,584,000 | 1.54% |
| Lamond Capital Partners LLC | 68,780 | $1,463,000 | 1.48% |
| Green Owl Capital Management, LLC | 90,000 | $1,914,000 | 1.36% |
| Baker Brothers Advisors | 4,190,594 | $89,134,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,514 | $4,924,000 | 0.48% |
| Redmile Group, LLC | 238,121 | $5,065,000 | 0.42% |
| Highlander Capital Management, LLC | 19,250 | $409,000 | 0.37% |
| Spark Investment Management LLC | 110,500 | $2,350,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 145,380 | $3,092,000 | 0.24% |